Jacksonville, FL, United States of America

Andrew David Lee

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Vincere Biosciences, Inc.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew David Lee. Retrieved from https://idiyas.com/inventor/andrew-david-lee-1eipvuhj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Andrew David Lee

Introduction

Andrew David Lee is an accomplished inventor based in Jacksonville, FL. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that target specific biological pathways. His work is characterized by a focus on innovative solutions for medical challenges.

Latest Patents

Andrew holds a patent for "USP30 inhibitors and uses thereof." This invention provides compounds and compositions that inhibit USP30, along with methods for treating disorders mediated by this protein. His patent represents a crucial advancement in the treatment of various medical conditions.

Career Highlights

Andrew is currently employed at Vincere Biosciences, Inc., where he continues to push the boundaries of scientific research and innovation. His dedication to developing new therapeutic strategies has positioned him as a key figure in his field.

Collaborations

Andrew collaborates with talented professionals, including Donna Lee Romero and Michael G Johnson. These partnerships enhance the research environment and foster innovative ideas that contribute to their shared goals.

Conclusion

Andrew David Lee's work exemplifies the spirit of innovation in biotechnology. His contributions, particularly in the area of USP30 inhibitors, highlight the importance of targeted therapies in modern medicine. His ongoing efforts at Vincere Biosciences, Inc. continue to pave the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…